BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7753751)

  • 21. Both retinoic-acid-receptor- and retinoid-X-receptor-dependent signalling pathways mediate the induction of the brown-adipose-tissue-uncoupling-protein-1 gene by retinoids.
    Alvarez R; Checa M; Brun S; Viñas O; Mampel T; Iglesias R; Giralt M; Villarroya F
    Biochem J; 2000 Jan; 345 Pt 1(Pt 1):91-7. PubMed ID: 10600643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for the involvement of retinoic acid receptor RAR alpha-dependent signaling pathway in the induction of tissue transglutaminase and apoptosis by retinoids.
    Zhang LX; Mills KJ; Dawson MI; Collins SJ; Jetten AM
    J Biol Chem; 1995 Mar; 270(11):6022-9. PubMed ID: 7890733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of retinoid X receptors and COUP-TFI in a human salivary gland adenocarcinoma cell line.
    Kyakumoto S; Nemoto T; Sato N; Ota M
    Biochem Cell Biol; 1997; 75(6):749-58. PubMed ID: 9599664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suprabasal expression of a dominant-negative RXR alpha mutant in transgenic mouse epidermis impairs regulation of gene transcription and basal keratinocyte proliferation by RAR-selective retinoids.
    Feng X; Peng ZH; Di W; Li XY; Rochette-Egly C; Chambon P; Voorhees JJ; Xiao JH
    Genes Dev; 1997 Jan; 11(1):59-71. PubMed ID: 9000050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids.
    Sheikh MS; Shao ZM; Li XS; Dawson M; Jetten AM; Wu S; Conley BA; Garcia M; Rochefort H; Fontana JA
    J Biol Chem; 1994 Aug; 269(34):21440-7. PubMed ID: 8063776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells.
    Dawson MI; Chao WR; Pine P; Jong L; Hobbs PD; Rudd CK; Quick TC; Niles RM; Zhang XK; Lombardo A
    Cancer Res; 1995 Oct; 55(19):4446-51. PubMed ID: 7671258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of the ability of retinoids to inhibit promoter-induced anchorage-independent growth of JB6 mouse epidermal cells with their activation of retinoic acid receptor gamma.
    Rudd CJ; Mansbridge JN; Suing KD; Dawson MI
    Cancer Lett; 1993 Sep; 73(1):41-9. PubMed ID: 8402597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand-dependent activation of transcription in vitro by retinoic acid receptor alpha/retinoid X receptor alpha heterodimers that mimics transactivation by retinoids in vivo.
    Dilworth FJ; Fromental-Ramain C; Remboutsika E; Benecke A; Chambon P
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1995-2000. PubMed ID: 10051583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinoic acid (RA) receptor transcriptional activation correlates with inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase (ODC) activity by retinoids: a potential role for trans-RA-induced ZBP-89 in ODC inhibition.
    Dawson MI; Park JH; Chen G; Chao W; Dousman L; Waleh N; Hobbs PD; Jong L; Toll L; Zhang X; Gu J; Agadir A; Merchant JL; Bai L; Verma AK; Thacher SM; Chandraratna RA; Shroot B; Hill DL
    Int J Cancer; 2001 Jan; 91(1):8-21. PubMed ID: 11149424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.
    Zacheis D; Dhar A; Lu S; Madler MM; Klucik J; Brown CW; Liu S; Clement F; Subramanian S; Weerasekare GM; Berlin KD; Gold MA; Houck JR; Fountain KR; Benbrook DM
    J Med Chem; 1999 Oct; 42(21):4434-45. PubMed ID: 10543887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of retinoic acid receptor beta is associated with inhibition of keratinization in human head and neck squamous carcinoma cells.
    Zou CP; Hong WK; Lotan R
    Differentiation; 1999 Jan; 64(2):123-32. PubMed ID: 10234809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinoid regulation of the phosphoenolpyruvate carboxykinase gene in liver.
    Shin DJ; Odom DP; Scribner KB; Ghoshal S; McGrane MM
    Mol Cell Endocrinol; 2002 Sep; 195(1-2):39-54. PubMed ID: 12354671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Retinoids: mechanisms of action].
    Berbis P
    Ann Dermatol Venereol; 2010 Nov; 137 Suppl 3():S97-103. PubMed ID: 21185985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of HL-60 differentiation by a new class of retinoids with selective activity on retinoid X receptor.
    Apfel CM; Kamber M; Klaus M; Mohr P; Keidel S; LeMotte PK
    J Biol Chem; 1995 Dec; 270(51):30765-72. PubMed ID: 8530518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids.
    Beard RL; Chandraratna RA; Colon DF; Gillett SJ; Henry E; Marler DK; Song T; Denys L; Garst ME; Arefieg T
    J Med Chem; 1995 Jul; 38(15):2820-9. PubMed ID: 7636843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of apoptosis in MCF-7 breast carcinoma cell line by RAR and RXR selective retinoids.
    Toma S; Isnardi L; Riccardi L; Bollag W
    Anticancer Res; 1998; 18(2A):935-42. PubMed ID: 9615744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Genetic control of the development by retinoic acid].
    Mark M; Kastner P; Ghyselinck NB; Krezel W; Dupé V; Chambon P
    C R Seances Soc Biol Fil; 1997; 191(1):77-90. PubMed ID: 9181129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of RAR-beta 2 gene expression in embryos and RAR-beta 2 transactivation by the synthetic retinoid Ro 13-6307 correlates with its high teratogenic potency.
    Soprano DR; Tairis N; Gyda M; Harnish DC; Jiang H; Soprano KJ; Kochhar DM
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):159-63. PubMed ID: 8397452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The retinoic acid receptor-beta 2 contains two separate cell-specific transactivation domains, at the N-terminus and in the ligand-binding domain.
    Folkers GE; van der Leede BJ; van der Saag PT
    Mol Endocrinol; 1993 Apr; 7(4):616-27. PubMed ID: 8389001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conformationally defined 6-s-trans-retinoic acid analogs. 2. Selective agonists for nuclear receptor binding and transcriptional activity.
    Alam M; Zhestkov V; Sani BP; Venepally P; Levin AA; Kazmer S; Li E; Norris AW; Zhang XK; Lee MO
    J Med Chem; 1995 Jun; 38(13):2302-10. PubMed ID: 7608895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.